EGFR and non-small cell lung carcinoma: In our dataset of NSCLC subjects with activating EGFR mutations, we demonstrated an independent predictive value of intratumoral heterogeneity for early EGFR TKI failure measured by textural parameters in pretreatment FDG-PET/CT.